SAM
KYTH

Sandell Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Sandell Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,100
Closed -$3.01M – 45
2015
Q3 		$3.01M Sell
40,100
-105,430
-72% -$7.87M 0.47% 31
2015
Q2 		$11M Buy
+145,530
New +$7.8M 1.16% 32

Sandell Asset Management's KYTH Position: Q4 2015 in Review

Sandell Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 40,100 shares — an estimated $3.01M sold.

Sandell Asset Management first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $11M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Sandell Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Sandell Asset Management sold 40,100 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $3.01M.
  • Sandell Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Sandell Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $11M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Sandell Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.